Total Payments
$99,518
2024 Payments
$7,880
Companies
16
Transactions
152
Medicare Patients
2,417
Medicare Billing
$290,666
Payment Breakdown by Category
Consulting$75,134 (75.5%)
Travel$10,799 (10.9%)
Other$10,173 (10.2%)
Food & Beverage$3,325 (3.3%)
Education$87.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $75,134 | 34 | 75.5% |
| Travel and Lodging | $10,799 | 25 | 10.9% |
| Honoraria | $5,950 | 2 | 6.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,223 | 2 | 4.2% |
| Food and Beverage | $3,325 | 87 | 3.3% |
| Education | $87.00 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $27,237 | 37 | $0 (2023) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $26,954 | 24 | $0 (2024) |
| Genentech USA, Inc. | $15,461 | 14 | $0 (2022) |
| H. Lundbeck A S | $8,074 | 5 | $0 (2021) |
| PFIZER INC. | $7,195 | 6 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $5,474 | 17 | $0 (2019) |
| Biogen, Inc. | $3,132 | 1 | $0 (2022) |
| Allergan, Inc. | $2,561 | 31 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $1,450 | 1 | $0 (2024) |
| Alkermes, Inc. | $1,087 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,880 | 9 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($6,345) |
| 2023 | $7,446 | 20 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($4,197) |
| 2022 | $27,901 | 40 | Otsuka America Pharmaceutical, Inc. ($12,219) |
| 2021 | $7,706 | 7 | H. Lundbeck A S ($2,800) |
| 2020 | $2,276 | 8 | Allergan, Inc. ($2,276) |
| 2019 | $38,525 | 48 | Genentech USA, Inc. ($13,361) |
| 2018 | $6,700 | 15 | Otsuka America Pharmaceutical, Inc. ($6,550) |
| 2017 | $1,084 | 5 | Sunovion Pharmaceuticals Inc. ($1,059) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,410.00 | General |
| 12/04/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $16.75 | General |
| 11/06/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: CNS | ||||||
| 06/08/2024 | ABBVIE INC. | NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: PLASTIC SURGERY | ||||||
| 05/22/2024 | Janssen Scientific Affairs, LLC | — | Consulting Fee | Cash or cash equivalent | $1,450.00 | General |
| 05/16/2024 | GENZYME CORPORATION | ENJAYMO (Biological) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Hematology | ||||||
| 04/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/12/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,880.00 | General |
| 03/05/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Consulting Fee | Cash or cash equivalent | $3,055.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,410.00 | General |
| 08/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $117.47 | General |
| Category: Oncology | ||||||
| 08/10/2023 | ABBVIE INC. | NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: PLASTIC SURGERY | ||||||
| 05/22/2023 | Otsuka America Pharmaceutical, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| 05/03/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $64.24 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/22/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $426.08 | General |
| Category: Musculoskeletal | ||||||
| 03/17/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Musculoskeletal | ||||||
| 03/07/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,880.00 | General |
| 03/07/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $51.99 | General |
| Category: PSYCHIATRY | ||||||
| 03/07/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $14.97 | General |
| Category: PSYCHIATRY | ||||||
| 03/07/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $3.85 | General |
| Category: PSYCHIATRY | ||||||
| 02/18/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $31.50 | General |
| Category: Musculoskeletal | ||||||
| 02/08/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $689.21 | General |
| Category: PSYCHIATRY | ||||||
| 02/08/2023 | Otsuka America Pharmaceutical, Inc. | — | Consulting Fee | Cash or cash equivalent | $470.00 | General |
| 02/08/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $42.52 | General |
| Category: PSYCHIATRY | ||||||
| 02/08/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 644 | 1,080 | $268,777 | $64,565 |
| 2022 | 9 | 595 | 999 | $315,446 | $77,716 |
| 2021 | 6 | 575 | 1,134 | $376,008 | $90,225 |
| 2020 | 5 | 603 | 937 | $266,663 | $58,159 |
Total Patients
2,417
Total Services
4,150
Medicare Billing
$290,666
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 229 | 452 | $148,640 | $34,765 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 102 | 102 | $53,834 | $11,337 | 21.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 52 | 52 | $16,224 | $6,206 | 38.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 45 | $21,899 | $5,385 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 73 | $14,778 | $3,677 | 24.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $7,743 | $1,819 | 23.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 16 | 20 | $3,060 | $766.60 | 25.1% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 137 | 325 | $2,600 | $609.01 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 252 | 620 | $199,000 | $48,045 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 117 | 117 | $58,985 | $14,239 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 110 | 142 | $31,881 | $7,954 | 25.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 24 | 24 | $7,488 | $3,007 | 40.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 17 | $8,948 | $2,172 | 24.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 26 | 27 | $4,131 | $1,038 | 25.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $3,950 | $990.60 | 25.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 23 | 23 | $621.00 | $206.48 | 33.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 16 | 17 | $442.00 | $63.60 | 14.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 318 | 841 | $284,757 | $68,531 | 24.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 87 | 87 | $43,028 | $9,785 | 22.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 104 | 127 | $28,382 | $7,099 | 25.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 20 | $9,556 | $2,532 | 26.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 37 | 46 | $7,038 | $1,676 | 23.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $3,248 | $602.21 | 18.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 282 | 526 | $155,552 | $34,641 | 22.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 101 | 101 | $52,978 | $10,841 | 20.5% |
About Dr. William Jackson, MD
Dr. William Jackson, MD is a Family Medicine healthcare provider based in Germantown, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407858368.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Jackson, MD has received a total of $99,518 in payments from pharmaceutical and medical device companies, with $7,880 received in 2024. These payments were reported across 152 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($75,134).
As a Medicare-enrolled provider, Jackson has provided services to 2,417 Medicare beneficiaries, totaling 4,150 services with total Medicare billing of $290,666. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Hospice and Palliative Medicine
- Location Germantown, TN
- Active Since 08/11/2005
- Last Updated 09/24/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1407858368
Products in Payments
- REXULTI (Drug) $34,404
- DASOTRALINE (Drug) $4,375
- VRAYLAR (Drug) $1,304
- LATUDA (Drug) $1,100
- Xeomin (Biological) $589.97
- BOTOX (Biological) $286.40
- Nubeqa (Drug) $117.47
- NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) $99.11
- BOTOX COSMETIC (Biological) $83.62
- INJECTAFER (Drug) $26.08
- LYBALVI (Drug) $18.88
- VIVITROL (Drug) $18.57
- ENJAYMO (Biological) $15.78
- Ethyol (Drug) $12.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Germantown
Dr. John Crawford, Md, MD
Family Medicine — Payments: $27,065
Family Medicine $27,065
Hugo Caballero, M.d, M.D
Family Medicine — Payments: $16,957
Family Medicine $16,957
Robert Humphreys, Md, MD
Family Medicine — Payments: $11,909
Family Medicine $11,909
Gregory Laurence, Md, MD
Family Medicine — Payments: $11,720
Family Medicine $11,720
Dr. Avni Jain, M.d., M.b.b.s, M.D., M.B.B.S
Family Medicine — Payments: $3,277
Family Medicine $3,277
Dr. Joseluis Jimenez, M.d, M.D
Family Medicine — Payments: $3,153
Family Medicine $3,153